This Week in Cardiology cover image

Nov 18, 2022, This Week in Cardiology

This Week in Cardiology

00:00

Is There a Benefit From Support?

The primary endpoint occurred in 64 patients in the ECMO group. The two main components of that endpoint, death and resuscitated cardiac arrest, showed no differences. These results places this trial in line with other cutagenic shock support trials. A smaller VA ECMO study also failed to show benefit over medical therapy.

Play episode from 12:31
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app